# Axcelis Technologies Inc: Form 10-Q for the period ended Sep 30, 2012

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2012-11-05
- Accepted by EDGAR: Nov 5, 2012, 15:29 ET
- Period: 2012-09-30
- Accession: 0001104659-12-074161
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000110465912074161/a12-19051_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000110465912074161/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-07-01 to 2012-09-30 | $44.6m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2012-01-01 to 2012-09-30 | $158.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2012-07-01 to 2012-09-30 | $30.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2012-01-01 to 2012-09-30 | $101.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2012-07-01 to 2012-09-30 | $14.4m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2012-01-01 to 2012-09-30 | $57.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2012-07-01 to 2012-09-30 | $9.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2012-01-01 to 2012-09-30 | $32.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2012-07-01 to 2012-09-30 | −$7.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-01-01 to 2012-09-30 | −$16.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2012-07-01 to 2012-09-30 | $243.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2012-01-01 to 2012-09-30 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-07-01 to 2012-09-30 | −$8.7m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months, 2012-01-01 to 2012-09-30 | −$19.2m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2012-07-01 to 2012-09-30 | −$0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2012-01-01 to 2012-09-30 | −$0.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-07-01 to 2012-09-30 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2012-01-01 to 2012-09-30 | −$0.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-07-01 to 2012-09-30 | 107,855,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2012-01-01 to 2012-09-30 | 107,521,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2012-01-01 to 2012-09-30 | −$11.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2012-01-01 to 2012-09-30 | $536.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-09-30 | $35.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-09-30 | $188.5m | us-gaap:AssetsCurrent |
| Total assets | at 2012-09-30 | $236.6m | us-gaap:Assets |
| Current liabilities | at 2012-09-30 | $31.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-09-30 | $37.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2012-09-30 | $199.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1113232/000110465912074161/a12-19051_110q.htm

Filed Nov 5, 2012.
Source: SEC EDGAR, the filing index for accession 0001104659-12-074161. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
